GENEVA, July 6 -- THE ASAN FOUNDATION filed a patent application (KR2025/022601) for “EDN BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO ANTIBODY THERAPEUTIC AGENT FOR ASTHMA”. With publication no. WO/2026/142272, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12Q 1/6883
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....